Evidence supporting the use of: Salidroside
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Salidroside, a bioactive compound extracted from Rhodiola rosea, has garnered scientific interest for its potential neuroprotective properties, particularly relevant to neurodegenerative diseases like Parkinson's Disease (PD). Preclinical studies—primarily in cell cultures and animal models—have demonstrated that salidroside can exert antioxidant, anti-apoptotic, and anti-inflammatory effects. These actions are significant in the context of PD, which is characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra, largely driven by oxidative stress and mitochondrial dysfunction.

Several studies have shown that salidroside administration reduces neuronal death, inhibits mitochondrial dysfunction, and suppresses inflammatory pathways in models of PD induced by toxins such as MPTP or 6-OHDA. For example, a 2013 study in Neuroscience Letters showed that salidroside protected dopaminergic neurons and improved behavioral outcomes in MPTP-lesioned mice. Mechanistically, these effects are attributed to activation of the PI3K/Akt pathway and upregulation of endogenous antioxidant defenses.

However, despite encouraging preclinical data, there is a lack of robust clinical trials in humans evaluating salidroside’s efficacy and safety for PD. Thus, while there is some scientific rationale and early evidence, its use for Parkinson’s Disease remains experimental and cannot be considered evidence-based therapy at this time.

More about Salidroside
More about Parkinson's Disease

Products containing Salidroside

We currently have no products on Vitabase that contain this ingredient.